---

Client

• Middle America - Louisiana based biotechnology company specializing in innovative cancer treatments

Client Need

• Investments and partnering to further develop its technologies and pipeline.

 Solution Approach

• Aagami scanned the global market, identified right investors/ partners, and took them to 50 + companies. 
• With focused efforts 10+ companies had post CDA level scientific and clinical discussions. 
• Aagami kept facilitating and persevering, 3 companies moved to term sheet level discussions.
• Finally Aagami found a right partner to facilitate reverse merger with a OTC Markets listed company.
• This is enabling access to large sums of funds  to develop clinical stage programs.

Results

• Listing on OTC Markets by a reverse merger
• Financial resources to enable development of existing pipeline and technologies